Pentobarbital decreases outcomes of hemin by pharmacodynamic antagonism. Use Warning/Check. Prescription drugs that raise delta-aminolevulinic acid synthetase may well lessen hemin result. pentobarbital will minimize the extent or outcome of roflumilast by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration not encouraged; powerful cytochrome P450 ... https://anthonyp307vad8.wikilima.com/user